Dear Bhawani and other members of the list, On account of relative physical inaction & inability to go for a swift walk, the visually impaired persons have a higher probability of diabetes attack. In my opinion any discussion on diabetes is very pertinent to visually impaired persons in general and to this site in particular. Actually when I saw Vijeta's mail, which in my opinion was very informative and interesting I was only hoping that one of us should not blow the whistle in the context of the topical importance. Before blowing the whistle, we should put the general interest of the site before our personal interests, tastes & preferences. e.g. we had an extended & perhaps interminable discussion on stray dogs and many of us shared our experience on the site on the way they were kissed and bit by dogs. While this many not be pertinent to some of us on an individual basis, it is of common interest. I request that before blowing the whistle, which in my opinion should be best left to the moderator let us ask ourselves whether the topic under discussion is of common importance pertaining to visually impaired. Some of us raised an objection when an incident involving an IT professional in Bangalore was posted. I also feel that we should not recommend any of our members to post their messages in any other specific site. I hope this is appreciated.
Rgds, (K. Ramkrishna) 23.9.06 ----- Original Message ----- From: "BHAWANI SHANKAR VERMA" <[EMAIL PROTECTED]> To: <[email protected]> Sent: Friday, September 22, 2006 10:40 AM Subject: Re: [AI] diabetes > please discuss such matter in another group called "say everything". this > is > not an appropriate forum for such discussion. thanks. > > ----- Original Message ----- > From: "vijeta" <[EMAIL PROTECTED]> > To: <[email protected]> > Sent: Thursday, September 21, 2006 5:22 PM > Subject: [AI] diabetes > > >> >> Diabetes >> >> Diabetes >> >> Diabetes is classified into four catagories with slightly varied > therapeutic protocols that our customers have seen phenomenal results > with. >> >> Diabetes is a major health concern globally. According to the National > Daibetes Association, 16 million people in the U.S. have diabetes and less > than 1/2 >> aren' t even aware that they have it. >> >> Diabetes ranks as the number 4 cause death in America with 178,000 > assocaited deaths annually. 18 - 24,000 people lose their eyesight and > more > than 20,000 >> diabetics are treated for renal disease. Diabetes is the most frequent > cause of non- traumatic loss of limbs each year. >> >> The protocol for Brittle diabetes, Diabetes Insipidus, Diabetes Mellitus > Type I, Diabetes Mellitus Type II are excellent specific complementary > therapies. >> >> Central to all kits is the DNA insulin product that is homeopathically > proven to re-teach the pancreas optimal insulin production thereby > correcting hereditary >> diabetic predispositions.* DNA insulin contains energetic imprints from > optimally working pancreatic tissues, non-diabetic DNA and Insulin and > serves to >> remind the body of correct pancreatic function. When taken over a period > of time the body begins to relearn insulin production. DNA Insulin > manufactured >> exclusively by PHP labs is truly a breakthrough in Diabetes therapies and > resonance homeopathy. It is not neccesary to continue taking DNA Insulin > past >> a 3 or 6 month adaptation period. We believe in addressing root causes >> and > not just supressing symptoms. >> >> The kits all also contain PROZN-GL >> US Patent # 5,834,032(Cyclo his-pro plus Zinc) >> which showed improvements in biochemical measures of glucose metabolism >> in > double-blind studies at UCLA. Cyclo (his-pro) is a naturally occurring > cyclic >> dipeptide consisting of histidyl and proline. Concentrations of cyclo > (his-pro) have been found in the blood, cerebrospinal fluid (CSF), semen, > brain, >> spinal cord, and gastrointestinal tract of humans. Studies suggest that > cyclo (his-pro) is one of numerous compounds in the prostate gland that > regulate >> the intestinal absorption of zinc.Both animals and humans with diabetes > have altered zinc metabolism and zinc is known to play a key role in > synthesis, >> storage, and secretion of insulin. Zinc is also required for proper > glucose utilization by muscle and fat cells. PROZN_GL enhances both zinc > absorption >> and glucose utilization, which results in a significant decline in both > blood and urine glucose levels of diabetic patients.* It appears that > cyclo > (his-pro) >> is an important new agent that can help improve glucose metabolism in > patients with type diabetes. >> >> It is important to monitor your blood sugar and insulin and eat a proper > diet while on these complementary protocols. These products are not a > substitute >> for any pharmaceuticals that your Dr. may have prescribed. >> Hypoglycemics and Borderline Diabetes >> >> >> Hypoglycemics and Borderline Diabetes: >> >> >> The kit for hypoglycemics and borderline diabetics contains ProZnGL, DNA > Insulin and Glucogen Complex >> >> ProZn GL US Patent # 5,834,032. PROZN_GL enhances both zinc absorption > and glucose utilization, which results in a significant decline in both > blood and >> urine glucose levels of diabetic patients.* >> >> C19 DNA - Aids in correcting hereditary diabetes by re-teaching the body > insulin production >> >> SGC Glucogen Complex 120 capsules. Is a metabolic product that helps to > regulate sugar levels and insulin. >> >> Dr. vijeta >> To unsubscribe send a message to [EMAIL PROTECTED] > with the subject unsubscribe. >> >> To change your subscription to digest mode or make any other changes, > please visit the list home page at >> > http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in >> > > > DISCLAIMER: > The Information transmitted in this email is solely for the addressee. It > is confidential and may be legally privileged. Access to this email by > anyone else is unauthorized. Any disclosure, copying, distribution or any > action taken by anyone other than by the intended recipient is prohibited > and may be unlawful. If you are not the intended recipient then kindly > delete the mail from your system. Any opinion or views expressed in this > mail may not necessarily reflect that of Punjab National Bank. The bank > considers unencrypted email as an insecure mode of communication. > > To unsubscribe send a message to [EMAIL PROTECTED] > with the subject unsubscribe. > > To change your subscription to digest mode or make any other changes, > please visit the list home page at > http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in > --------------------------------------------------------------------------------------------------------------------- This e-mail contains privileged information or information belonging to IDBI Ltd. and is intended solely for the addressee/s. Access to this email by anyone else is unauthorized. Any copying (whole or partial) or further distribution beyond the original recipient is not intended, and may be unlawful. The recipient acknowledges that IDBI Ltd. is unable to exercise control or ensure or guarantee the integrity of the contents of the information contained in e-mail transmissions and further acknowledges that any views expressed in this message are those of the individual sender and are not binding on IDBI Ltd. E-mails are susceptible to alteration and their integrity cannot be guaranteed. IDBI Ltd. does not accept any liability for damages caused on account of this e-mail. If you have received this email in error, please contact the sender and delete the material from your computer. --------------------------------------------------------------------------------------------------------------------- To unsubscribe send a message to [EMAIL PROTECTED] with the subject unsubscribe. To change your subscription to digest mode or make any other changes, please visit the list home page at http://accessindia.org.in/mailman/listinfo/accessindia_accessindia.org.in
